comparemela.com

Latest Breaking News On - Mines canada inc - Page 3 : comparemela.com

NA Proactive news snapshot: Weekend Unlimited Inc aka Potent Ventures Inc, CytoDyn Inc, PlantX Life Inc, PyroGenesis Canada Inc, Global Energy Metals Corporation, MagicMed Industries Inc,

NA Proactive news snapshot: Weekend Unlimited Inc aka Potent Ventures Inc, CytoDyn Inc, PlantX Life Inc, PyroGenesis Canada Inc, Global Energy Metals Corporation, MagicMed Industries Inc,
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

FTSE 100 declines despite modest rise by sterling against the dollar

FTSE 100 declines despite modest rise by sterling against the dollar Companies Follow John on: FTSE 100 declines despite modest rise by sterling against the dollar It was a dull day in London, but New York appears headed in the right direction after a negative open Tesla schmesla FTSE 250 sheds 144 points (0.6%) Serco higher after landing government contracts 5.05pm: FTSE ends lower, US indices shake off morning rust London s leading index closed Tuesday down 18 points, 0.3%, at 6,945, while the FTSE 250 lost 144 points, 0.6%, to 22, 433. European markets have struggled to maintain recent gains today, with the US open driving weakness on both sides of the Atlantic, IG Senior Market Analyst Joshua Mahony wrote.  The recent shift in emphasis for traders has seen vaccination and reopening concerns replaced with a raft of earnings announcements that should help shape expectations for wider sector performance over Q1.

NA Proactive news snapshot: PlantX Life Inc, PyroGenesis Canada Inc, Global Energy Metals Corporation, MagicMed Industries Inc UPDATE …

A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Weekend Unlimited Inc (CSE:POT) (OTCQB:WKULF), a North American recreational cannabis and CBD wellness company, announced that it intends to change its name to Potent Ventures Inc. The Vancouver-based group also said that it plans to subdivide its common shares based on four new shares for every one existing common share. The company said that as part of the share split, registered shareholders of the company will receive four shares for each share held as of April 28, 2021. Weekend will continue to trade under its iconic CSE stock symbol POT.

NA Proactive news snapshot: Cloud DX Inc, New Oroperu Resources Inc, Todos Medical Ltd, Kainantu Resources Ltd, CleanSpark Inc, Arcadia Biosciences Inc UPDATE …

NA Proactive news snapshot: Cloud DX, New Oroperu Resources, Todos Medical, Kainantu Resources, CleanSpark UPDATE … A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Cloud DX Inc (CVE:CDX) said Brad Miller, a director of the company (formerly Roosevelt Capital Group), as a result of the previously announced qualifying transaction and related transactions, had acquired beneficial ownership and control over 7,307,337 shares and 100,000 share purchase warrants issued to B and M Miller Equity Holdings Inc -  an entity controlled by Mr Miller. The shares and warrants were issued in exchange for the securities of Cloud Canada held by B&M prior to completion of the qualifying transaction. As a result of the qualifying transaction, B&M has ownership and control over 10.13% of the shares on a non-diluted basis and around 10.28% of the  shares on a partially diluted basis assuming t

NA Proactive news snapshot: Todos Medical Ltd, Kainantu Resources Ltd, CleanSpark Inc, Arcadia Biosciences Inc UPDATE …

NA Proactive news snapshot: Todos Medical, Kainantu Resources, CleanSpark, Arcadia Biosciences UPDATE … A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Todos Medical Ltd (OTCQB:TOMDF) has announced the initiation of a randomized, double-blind, placebo-controlled Phase 2 clinical trial of antiviral Tollovir for the treatment of hospitalized coronavirus (COVID-19) patients. The trial is being conducted at Shaare Zedek Medical Center in Jerusalem, Israel, and will evaluate the safety and efficacy of Tollovir, the company said. Tollovir is a patent-pending therapeutic agent being developed through a joint venture between Todos and NLC Pharma. It is among 3CL protease inhibitors that are targeted as desirable candidates for the development of antiviral therapies against SARS-CoV-2, the virus that causes the COVID-19 disease.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.